Internal jugular vein stenting for symptomatic severe rotational stenosis

View at publisher
Authors: Kyle M Fargen, Omar Ashraf, Allison Medina, Jackson P Midtlien, Connor Margraf, Molly R Ehrig, Carol Kittel, Jan Angela Vargas, Charles Stout, Adnan Siddiqui, Ferdinand Hui
Cited by: 3
References: 27

Abstract

BACKGROUND: Dynamic internal jugular vein (IJV) stenosis is increasingly recognized in patients with cerebral venous outflow disorders (CVD). Although the hemodynamic effects of dynamic jugular stenosis have been characterized, its role in disease remains undefined. This study evaluated the safety and early outcomes of IJV stenting for symptomatic rotational stenosis. METHODS: This retrospective, single-institution study included adult patients that underwent IJV stenting for dynamic, symptomatic IJV stenosis between 2023 and 2025. Inclusion required dynamic venography demonstrating >75% rotational IJV stenosis and ≥6 mmHg trans-stenotic pressure gradient. Demographic, procedural, and clinical data were analyzed. Symptom severity was assessed using the Cerebral Venous Disorder Symptom Severity (CVDSS) scale and the Headache Impact Test (HIT-6). RESULTS: Sixteen patients (mean age 37.1 years, 75% female) were included. All underwent successful IJV stent placement without periprocedural complications. The median trans-stenotic pressure gradient improved from 7 mmHg (range 6-18) to 1 mmHg (range 0-9) after stenting. CVDSS scores improved from 13.5 (11.0-16.0) to 8.5 (4.75-12.0) at peak improvement (p

Fields of Study & Subjects

Cerebral Venous Sinus Thrombosis Central Venous Catheters and Hemodialysis Vascular Malformations Diagnosis and Treatment

Publication details

Journal / source
Journal of NeuroInterventional Surgery
Publisher
BMJ
Pages
jnis–2025
Publication date
14 January 2026
Language
EN